Loading…

Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis

Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China. We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge In...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2016-01, Vol.11 (1), p.e0146659-e0146659
Main Authors: Huan, Zhou, Fuzhi, Wang, Lu, Liu, Min, Zhang, Xingzhi, Chen, Shiyang, Jin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3
cites cdi_FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3
container_end_page e0146659
container_issue 1
container_start_page e0146659
container_title PloS one
container_volume 11
creator Huan, Zhou
Fuzhi, Wang
Lu, Liu
Min, Zhang
Xingzhi, Chen
Shiyang, Jin
description Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China. We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I2 (and its 95% confidence intervals) and tau2 to assess between-study heterogeneity. We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I2 = 96.60%, 95%CI = 96.00%-97.20%; tau2 = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I2 = 86.20%, 95%CI = 60.00-95.20%; tau2 = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I2 = 31.3%, tau2 = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%). ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China.
doi_str_mv 10.1371/journal.pone.0146659
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1756066283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A439688031</galeid><doaj_id>oai_doaj_org_article_51f433f0d9314407bb301b3c3762bbb8</doaj_id><sourcerecordid>A439688031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3</originalsourceid><addsrcrecordid>eNptUtFqFDEUHUSxtfoHogFBfJmaTGYykz4Iw6K2UFFqfQ43k2Qn62wyJjMrC3682e62tGJeEs49OTnn5mbZS4JPCa3J-5Wfg4PhdPROn2JSMlbxR9kx4bTIWYHp43vno-xZjCuMK9ow9jQ7KlhdMUrZcfZn4dcjBBu9i8gb1KpeB-06jSaPWjfZoKfgNzbAgK5TCcYtsg4BOrfLPr-y8Sf65sd5gMl6t6sseuvgDLXo-zZOep3wDl3pjdW_ETiFvugJ8jb53kYbn2dPDAxRvzjsJ9mPTx-vF-f55dfPF4v2Mu-qqp5y0hhVy7pUlZEgmwLztBSveQ2SGcM5UxIqRSRgwpVJaEGbhDIDhlSNpCfZ673uOPgoDo2LgqQmYMaKhibGxZ6hPKzEGOwawlZ4sOIG8GEpIKQogxYVMSWlBitOSVniWkqKiaQdrVkhpWyS1ofDa7Nca9VpN6XuPRB9WHG2F0u_EWVNcMlxEnh3EAj-16zjJNY2dnoYwGk_73wz3FQlv_H95h_q_9O93bOWkAL0Goapj36Yd38WRVtSzpoGU5KI5Z7YBR9j0ObONcFiN3W38mI3deIwdenaq_uJ7y7djhn9C44m1fE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1756066283</pqid></control><display><type>article</type><title>Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Huan, Zhou ; Fuzhi, Wang ; Lu, Liu ; Min, Zhang ; Xingzhi, Chen ; Shiyang, Jin</creator><creatorcontrib>Huan, Zhou ; Fuzhi, Wang ; Lu, Liu ; Min, Zhang ; Xingzhi, Chen ; Shiyang, Jin</creatorcontrib><description>Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China. We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I2 (and its 95% confidence intervals) and tau2 to assess between-study heterogeneity. We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I2 = 96.60%, 95%CI = 96.00%-97.20%; tau2 = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I2 = 86.20%, 95%CI = 60.00-95.20%; tau2 = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I2 = 31.3%, tau2 = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%). ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0146659</identifier><identifier>PMID: 26756336</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acquired immune deficiency syndrome ; Adhesion ; AIDS ; Analysis ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Antiretroviral Therapy, Highly Active ; China ; Confidence intervals ; Disease transmission ; Dosage and administration ; Genetic transformation ; Health aspects ; Health risks ; Heterogeneity ; HIV ; HIV Infections - drug therapy ; HIV patients ; Human immunodeficiency virus ; Humans ; Medication Adherence ; Meta-analysis ; Patient compliance ; Patients ; Populations ; Pregnancy ; Pregnant women ; Publication Bias ; Regression Analysis ; Regression models ; Risk ; Risk Factors ; Statistical analysis ; Systematic review ; Therapy ; Transformation ; Womens health</subject><ispartof>PloS one, 2016-01, Vol.11 (1), p.e0146659-e0146659</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Huan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Huan et al 2016 Huan et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3</citedby><cites>FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1756066283/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1756066283?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25730,27900,27901,36988,36989,44565,53765,53767,75095</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26756336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huan, Zhou</creatorcontrib><creatorcontrib>Fuzhi, Wang</creatorcontrib><creatorcontrib>Lu, Liu</creatorcontrib><creatorcontrib>Min, Zhang</creatorcontrib><creatorcontrib>Xingzhi, Chen</creatorcontrib><creatorcontrib>Shiyang, Jin</creatorcontrib><title>Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China. We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I2 (and its 95% confidence intervals) and tau2 to assess between-study heterogeneity. We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I2 = 96.60%, 95%CI = 96.00%-97.20%; tau2 = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I2 = 86.20%, 95%CI = 60.00-95.20%; tau2 = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I2 = 31.3%, tau2 = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%). ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adhesion</subject><subject>AIDS</subject><subject>Analysis</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>China</subject><subject>Confidence intervals</subject><subject>Disease transmission</subject><subject>Dosage and administration</subject><subject>Genetic transformation</subject><subject>Health aspects</subject><subject>Health risks</subject><subject>Heterogeneity</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV patients</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Medication Adherence</subject><subject>Meta-analysis</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Populations</subject><subject>Pregnancy</subject><subject>Pregnant women</subject><subject>Publication Bias</subject><subject>Regression Analysis</subject><subject>Regression models</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>Statistical analysis</subject><subject>Systematic review</subject><subject>Therapy</subject><subject>Transformation</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUtFqFDEUHUSxtfoHogFBfJmaTGYykz4Iw6K2UFFqfQ43k2Qn62wyJjMrC3682e62tGJeEs49OTnn5mbZS4JPCa3J-5Wfg4PhdPROn2JSMlbxR9kx4bTIWYHp43vno-xZjCuMK9ow9jQ7KlhdMUrZcfZn4dcjBBu9i8gb1KpeB-06jSaPWjfZoKfgNzbAgK5TCcYtsg4BOrfLPr-y8Sf65sd5gMl6t6sseuvgDLXo-zZOep3wDl3pjdW_ETiFvugJ8jb53kYbn2dPDAxRvzjsJ9mPTx-vF-f55dfPF4v2Mu-qqp5y0hhVy7pUlZEgmwLztBSveQ2SGcM5UxIqRSRgwpVJaEGbhDIDhlSNpCfZ673uOPgoDo2LgqQmYMaKhibGxZ6hPKzEGOwawlZ4sOIG8GEpIKQogxYVMSWlBitOSVniWkqKiaQdrVkhpWyS1ofDa7Nca9VpN6XuPRB9WHG2F0u_EWVNcMlxEnh3EAj-16zjJNY2dnoYwGk_73wz3FQlv_H95h_q_9O93bOWkAL0Goapj36Yd38WRVtSzpoGU5KI5Z7YBR9j0ObONcFiN3W38mI3deIwdenaq_uJ7y7djhn9C44m1fE</recordid><startdate>20160112</startdate><enddate>20160112</enddate><creator>Huan, Zhou</creator><creator>Fuzhi, Wang</creator><creator>Lu, Liu</creator><creator>Min, Zhang</creator><creator>Xingzhi, Chen</creator><creator>Shiyang, Jin</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160112</creationdate><title>Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis</title><author>Huan, Zhou ; Fuzhi, Wang ; Lu, Liu ; Min, Zhang ; Xingzhi, Chen ; Shiyang, Jin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adhesion</topic><topic>AIDS</topic><topic>Analysis</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>China</topic><topic>Confidence intervals</topic><topic>Disease transmission</topic><topic>Dosage and administration</topic><topic>Genetic transformation</topic><topic>Health aspects</topic><topic>Health risks</topic><topic>Heterogeneity</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV patients</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Medication Adherence</topic><topic>Meta-analysis</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Populations</topic><topic>Pregnancy</topic><topic>Pregnant women</topic><topic>Publication Bias</topic><topic>Regression Analysis</topic><topic>Regression models</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>Statistical analysis</topic><topic>Systematic review</topic><topic>Therapy</topic><topic>Transformation</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huan, Zhou</creatorcontrib><creatorcontrib>Fuzhi, Wang</creatorcontrib><creatorcontrib>Lu, Liu</creatorcontrib><creatorcontrib>Min, Zhang</creatorcontrib><creatorcontrib>Xingzhi, Chen</creatorcontrib><creatorcontrib>Shiyang, Jin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huan, Zhou</au><au>Fuzhi, Wang</au><au>Lu, Liu</au><au>Min, Zhang</au><au>Xingzhi, Chen</au><au>Shiyang, Jin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-01-12</date><risdate>2016</risdate><volume>11</volume><issue>1</issue><spage>e0146659</spage><epage>e0146659</epage><pages>e0146659-e0146659</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China. We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I2 (and its 95% confidence intervals) and tau2 to assess between-study heterogeneity. We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I2 = 96.60%, 95%CI = 96.00%-97.20%; tau2 = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I2 = 86.20%, 95%CI = 60.00-95.20%; tau2 = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I2 = 31.3%, tau2 = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%). ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>26756336</pmid><doi>10.1371/journal.pone.0146659</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2016-01, Vol.11 (1), p.e0146659-e0146659
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1756066283
source Publicly Available Content Database; PubMed Central
subjects Acquired immune deficiency syndrome
Adhesion
AIDS
Analysis
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Antiretroviral Therapy, Highly Active
China
Confidence intervals
Disease transmission
Dosage and administration
Genetic transformation
Health aspects
Health risks
Heterogeneity
HIV
HIV Infections - drug therapy
HIV patients
Human immunodeficiency virus
Humans
Medication Adherence
Meta-analysis
Patient compliance
Patients
Populations
Pregnancy
Pregnant women
Publication Bias
Regression Analysis
Regression models
Risk
Risk Factors
Statistical analysis
Systematic review
Therapy
Transformation
Womens health
title Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T23%3A20%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparisons%20of%20Adherence%20to%20Antiretroviral%20Therapy%20in%20a%20High-Risk%20Population%20in%20China:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=PloS%20one&rft.au=Huan,%20Zhou&rft.date=2016-01-12&rft.volume=11&rft.issue=1&rft.spage=e0146659&rft.epage=e0146659&rft.pages=e0146659-e0146659&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0146659&rft_dat=%3Cgale_plos_%3EA439688031%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1756066283&rft_id=info:pmid/26756336&rft_galeid=A439688031&rfr_iscdi=true